BI-RADS Categories 4 and 5 Warrant FNAC
For breast lesions classified as BI-RADS categories 4 (suspicious abnormality) and 5 (highly suggestive of malignancy), tissue diagnosis is necessary, and fine-needle aspiration cytology (FNAC) is an acceptable option, though core needle biopsy (CNB) is preferred. 1
Evidence-Based Recommendations by BI-RADS Category
BI-RADS 1 and 2 (Negative/Benign)
- No FNAC indicated - routine screening only 1
BI-RADS 3 (Probably Benign)
- FNAC generally not indicated - short-interval follow-up mammography at 6 months is the standard approach 1
- Exception: FNAC may be considered if:
- Research shows only 6% malignancy rate in BI-RADS 3 lesions, supporting conservative management 4
BI-RADS 4 and 5 (Suspicious/Highly Suggestive of Malignancy)
- Tissue diagnosis mandatory 2, 1, 2
- CNB is preferred over FNAC due to superior accuracy 1
- FNAC remains acceptable when:
- CNB is not feasible
- Performed under imaging guidance (ultrasound/stereotactic)
- Adequate cytopathology expertise is available 1
BI-RADS 6 (Known Malignancy)
- Proceed directly to cancer management protocols 1
Critical Caveat: Pathology-Image Concordance
When FNAC is performed, concordance between cytology and imaging findings is absolutely mandatory. 2 For example:
- A negative FNAC result with a spiculated BI-RADS 5 mass is discordant and unacceptable 2
- When discordance occurs, repeat imaging and additional tissue sampling or surgical excision is required 2, 1
Why CNB is Preferred Over FNAC
The guidelines consistently favor CNB because:
- Higher accuracy for nonpalpable lesions 1
- Provides histologic architecture, not just cytology 1
- Eliminates need for follow-up biopsy when malignancy is confirmed 1
- Sensitivity of 97-99% for image-guided CNB 1
FNAC disadvantages include:
- Requires specialized cytopathology expertise 1
- Necessitates follow-up tissue biopsy when atypia or malignancy is identified 1
- Lower accuracy than CNB or excisional biopsy for nonpalpable lesions 1
Practical Algorithm
For BI-RADS 4 or 5 lesions:
- First choice: Image-guided CNB (stereotactic, ultrasound, or MRI-guided)
- Alternative: FNAC under imaging guidance if CNB unavailable
- Verify pathology-image concordance immediately
- If discordant → repeat imaging and obtain additional tissue or proceed to surgical excision
- If concordant benign → follow-up mammography every 6-12 months for 1-2 years 2, 1
Recent research validates the Yokohama System for standardizing FNAC reporting, showing high diagnostic accuracy (sensitivity 95.8%, specificity 92.1%) when properly implemented 5, though this does not change the guideline preference for CNB in BI-RADS 4-5 lesions.